These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 808340)

  • 41. Augmentation of 3H-thymidine incorporation by human lymphocytes in the presence of antigen and fractions of dialyzable transfer factor: a nonspecific phenomenon.
    Littman BH; Hirschman EM; David JR
    Cell Immunol; 1977 Jan; 28(1):158-66. PubMed ID: 64313
    [No Abstract]   [Full Text] [Related]  

  • 42. Transfer factor in vitro: chromatography of components that enhance antigen-induced lymphocyte proliferation.
    Andron LA; Ascher MS
    Clin Immunol Immunopathol; 1978 Feb; 9(2):157-65. PubMed ID: 618688
    [No Abstract]   [Full Text] [Related]  

  • 43. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.
    Sayegh MH; Khoury SJ; Hancock WW; Weiner HL; Carpenter CB
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7762-6. PubMed ID: 1502196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of transfer factor on lymphocyte transformation. Comparison of augmentation by dialysates of leucocytes and lymphoid and non-lymphoid organs.
    Uotila A; Hamblin A; Dumonde DC; Krohn KJ
    Int Arch Allergy Appl Immunol; 1978; 57(3):210-20. PubMed ID: 659013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of DNA synthesis in lymphocytes by dialyzable components of human leukocyte extracts.
    Saito K; Tamaki N; Foster LA; Brennessel B; Gottlieb AA
    Cell Immunol; 1977 Jun; 31(2):311-20. PubMed ID: 301440
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of human lymphoblastoid cell line proliferation by ascites fluids from ovarian cancer patients.
    Hess AD; Gall SA; Dawson JR
    Cancer Res; 1980 Dec; 40(12):4495-500. PubMed ID: 7438082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Herpesvirus papio: state and properties of intracellular viral DNA in baboon lymphoblastoid cell lines.
    Falk L; Lindahl T; Bjursell G; Klein G
    Int J Cancer; 1979 Jul; 24(1):75-9. PubMed ID: 113352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transformation of lymphocytes by Herpesvirus papio.
    Falk LA; Henle G; Henle W; Deinhardt F; Schudel A
    Int J Cancer; 1977 Aug; 20(2):219-26. PubMed ID: 197025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-mediated immunity in experimental filariasis: lymphocyte reactivity to filarial stage-specific antigens and to B- and T-cell mitogens during acute and chronic infection.
    Weller PF
    Cell Immunol; 1978 May; 37(2):369-82. PubMed ID: 306892
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunologic mechanism following liver transplantation. An experimental study in the rat].
    Lie TS; Galkowska H; Jaeger K; Niehaus KJ
    Langenbecks Arch Chir; 1983; 360(1):17-27. PubMed ID: 6348454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bovine 'transfer factor': an oligoribonucleopeptide which initiates antigen-specific lymphocytes responsiveness.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1982; 4(6):335-50. PubMed ID: 6191411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specificities in natural cell-mediated cytotoxicity against lymphoblastoid cell lines. I. Selective inhibition by cross-competition.
    Koide Y; Takasugi M
    Eur J Immunol; 1978 Nov; 8(11):818-22. PubMed ID: 82513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppressor cell infleunce in selected strains of inbred rats. II. Macrophage-associated suppression of cell-mediated immune responsiveness.
    Raff HV; Hinrichs DJ
    Cell Immunol; 1977 Mar; 29(1):109-17. PubMed ID: 300294
    [No Abstract]   [Full Text] [Related]  

  • 55. Co-culture of pancreatic islets and allogeneic lymphocytes: alterations of responder and stimulator cells.
    Kuttler B; Wanka H; Hahn HJ
    Transplantation; 1997 Aug; 64(3):480-9. PubMed ID: 9275116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specificity of the local transfer of cell-mediated immunity with dialyzable transfer factor.
    Gerbase-DeLima M; Carlquist I; Mendes NF
    Cell Immunol; 1979 Nov; 48(1):231-4. PubMed ID: 509535
    [No Abstract]   [Full Text] [Related]  

  • 58. Dialyzable leukocyte extract: partial purification of low-molecular-weight factors suppressing and enhancing lymphocyte transformation.
    Rosso di San Secondo VE; Lugaro G; Sirchia G
    J Exp Pathol; 1987; 3(4):425-7. PubMed ID: 3454803
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical study of a patient with lupus vulgaris before and after injection of dialyzable transfer factor.
    Horsmanheimo M; Krohn K; Virolainen M
    J Invest Dermatol; 1977 Jan; 68(1):10-5. PubMed ID: 318672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-mediated immune responsiveness of patients with acute lymphocytic leukemia in remission.
    Oldham RK; Weiner RS; Mathé G; Breard J; Simmler MC; Carde P; Herberman RB
    Int J Cancer; 1976 Mar; 17(3):326-37. PubMed ID: 1062362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.